| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.8 | $0-$5k | 0.00 |
Summary
A vulnerability identified as critical has been detected in EasyLobby Solo. Affected is an unknown function of the component Kiosk Mode. Performing a manipulation results in access control. This vulnerability is cataloged as CVE-2018-17491. The attack may be carried out on the physical device. Furthermore, there is an exploit available.
Details
A vulnerability, which was classified as critical, was found in EasyLobby Solo (affected version not known). This affects some unknown functionality of the component Kiosk Mode. The manipulation with an unknown input leads to a access control vulnerability. CWE is classifying the issue as CWE-284. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
EasyLobby Solo could allow a local attacker to gain elevated privileges on the system. By visiting the kiosk and typing "esc" to exit the program, an attacker could exploit this vulnerability to perform unauthorized actions on the computer.
The bug was discovered 03/04/2019. The weakness was shared 03/21/2019 (Website). The advisory is shared at exchange.xforce.ibmcloud.com. This vulnerability is uniquely identified as CVE-2018-17491 since 09/25/2018. An attack has to be approached locally. No form of authentication is needed for exploitation. Technical details are unknown but a public exploit is available. MITRE ATT&CK project uses the attack technique T1068 for this issue.
It is declared as proof-of-concept. The vulnerability was handled as a non-public zero-day exploit for at least 17 days. During that time the estimated underground price was around $0-$5k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The entries VDB-131890, VDB-131888 and VDB-131887 are related to this item. Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Name
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.8VulDB Meta Temp Score: 6.8
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.8
NVD Vector: 🔍
CNA Base Score: 8.4
CNA Vector (IBM Corporation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Access controlCWE: CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: Yes
Local: Yes
Remote: No
Availability: 🔍
Access: Public
Status: Proof-of-Concept
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
09/25/2018 🔍03/04/2019 🔍
03/21/2019 🔍
03/22/2019 🔍
08/03/2023 🔍
Sources
Advisory: exchange.xforce.ibmcloud.comStatus: Not defined
CVE: CVE-2018-17491 (🔍)
GCVE (CVE): GCVE-0-2018-17491
GCVE (VulDB): GCVE-100-131889
X-Force: 149651
scip Labs: https://www.scip.ch/en/?labs.20161013
See also: 🔍
Entry
Created: 03/22/2019 07:01Updated: 08/03/2023 09:47
Changes: 03/22/2019 07:01 (56), 05/17/2020 17:03 (1), 08/03/2023 09:46 (4), 08/03/2023 09:47 (12)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.